The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 18408578)

Published in Transplantation on April 15, 2008

Authors

Sita Gourishankar1, Karen Doucette, Jayne Fenton, Dale Purych, Kinga Kowalewska-Grochowska, Jutta Preiksaitis

Author Affiliations

1: Division of Nephrology and Transplantation, University of Alberta, Edmonton, Alberta, Canada. sitag@ualberta.ca

Articles by these authors

International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis (2005) 9.23

Multiplexed real-time PCR assay for discrimination of Plasmodium species with improved sensitivity for mixed infections. J Clin Microbiol (2009) 3.62

Management of chronic hepatitis C: consensus guidelines. Can J Gastroenterol (2007) 2.06

Post-arrival screening for malaria in asymptomatic refugees using real-time PCR. Am J Trop Med Hyg (2011) 1.89

Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis. Clin Infect Dis (2009) 1.86

Management of chronic hepatitis B: consensus guidelines. Can J Gastroenterol (2007) 1.78

Occult hepatitis B virus infection in a North American community-based population. J Hepatol (2005) 1.64

Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis (2011) 1.61

A commutable cytomegalovirus calibrator is required to improve the agreement of viral load values between laboratories. Clin Chem (2009) 1.59

Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis (2012) 1.47

A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation (2010) 1.35

Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ (2010) 1.18

Evaluation of the Do Bugs Need Drugs? program in British Columbia: Can we curb antibiotic prescribing? Can J Infect Dis Med Microbiol (2011) 1.04

A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients. Am J Transplant (2005) 1.03

Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation. J Clin Microbiol (2003) 1.03

An outbreak of E. coli O157:H7 hemorrhagic colitis associated with unpasteurized gouda cheese. Can J Public Health (2005) 1.01

The feasibility of using an 'opt-out' approach to achieve universal HIV testing of tuberculosis patients in Alberta. Can J Public Health (2009) 0.99

Treatment of hepatitis C in children: a systematic review. PLoS One (2010) 0.99

Automated screening using microfluidic chip-based PCR and product detection to assess risk of BK virus-associated nephropathy in renal transplant recipients. Electrophoresis (2006) 0.99

Clinical utility of commercial enzyme immunoassays during the inaugural season of West Nile virus activity, Alberta, Canada. J Clin Microbiol (2005) 0.98

pVir and bloody diarrhea in Campylobacter jejuni enteritis. Emerg Infect Dis (2005) 0.97

Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study. J Clin Microbiol (2007) 0.96

Infection of placental trophoblasts by Toxoplasma gondii. J Infect Dis (2003) 0.96

First report of Schistosoma mekongi infection with brain involvement. Clin Infect Dis (2003) 0.92

The laboratory diagnosis of herpes simplex virus infections. Can J Infect Dis Med Microbiol (2005) 0.91

Rapid HIV tests in acute care settings in an area of low HIV prevalence in Canada. J Virol Methods (2010) 0.90

Hepatitis C seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics. Sex Transm Dis (2003) 0.89

DIAL: A Platform for real-time Laboratory Surveillance. Online J Public Health Inform (2010) 0.88

A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation. J Heart Lung Transplant (2007) 0.87

H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactions. PLoS One (2013) 0.86

Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics. Sex Transm Dis (2005) 0.84

An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants. J Infect Dis (2009) 0.84

Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North American tertiary referral liver centres. Liver Int (2013) 0.83

Treatment of chronic hepatitis C in a Canadian Aboriginal population: results from the PRAIRIE study. Can J Gastroenterol (2013) 0.80

Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment. Can J Infect Dis (2002) 0.80

The INSTI HIV-1/HIV-2 antibody test: a review. Expert Opin Med Diagn (2013) 0.79

Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance. J Heart Lung Transplant (2006) 0.78

The natural history of hepatitis C virus infection acquired during childhood. Liver Int (2011) 0.78

Screening of organ and tissue donors for West Nile virus by nucleic acid amplification--a three year experience in Alberta. Am J Transplant (2008) 0.78

Use of anti-HCV-positive donor organs. Am J Transplant (2005) 0.76

Modeling the risk of an emerging pathogen entering the Canadian blood supply. Transfusion (2010) 0.76

Results of continuous monitoring of the performance of rubella virus IgG and hepatitis B virus surface antibody assays using trueness controls in a multicenter trial. Clin Vaccine Immunol (2012) 0.75

Metagenomics and the case of the deadly hamster. Hepatology (2008) 0.75

Severe chronic active Epstein-Barr virus infection mimicking steroid-dependent inflammatory bowel disease. Pediatr Infect Dis J (2005) 0.75

Sentinel surveillance of HIV and hepatitis C virus in two urban emergency departments. CJEM (2004) 0.75